Dr. Tolaney Discusses Pertuzumab in HER2+ Breast Cancer

Optimizing HER2-Positive Breast Cancer Therapy: Balancing Efficacy and ToxicityПодробнее

Dr. Mittendorf on the Impact of Pertuzumab in HER2+ Breast CancerПодробнее

Dr. Tolaney Discusses the Role of Chemotherapy in HER2+ Breast CancerПодробнее

Dr. Pegram on Pertuzumab Plus Trastuzumab and Chemotherapy in Breast CancerПодробнее

Dr. Pegram on Pertuzumab Combination for HER2-Positive Breast CancerПодробнее

Dr. Tolaney Discusses Neratinib in HER2+ Breast CancerПодробнее

Dr. Yardley on the APHINITY Trial for HER2-Positive Breast CancerПодробнее